A subtractive fluorescence-activated cell-sorting strategy to identify mimotopes of HBV–preS protein from bacterially displayed peptide library

A novel subtractive fluorescence-activated cell-sorting (FACS) strategy using a model system is described here to identify disease-specific (DS) epitopes from a bacterially displayed random peptide library. In this process, preimmune serum was used as “Driver ” to block any common binding sites on t...

Full description

Saved in:
Bibliographic Details
Published inJournal of immunological methods Vol. 293; no. 1; pp. 13 - 21
Main Authors Xin, Zhong-Tao, Liu, Chuan, Dong, Bo, Gao, Ya-Ping, Shao, Ning-Sheng, Liu, Wei, Zhang, Jie, Dong, Jie, Ling, Shi-Gan, Xue, Yan-Ning
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 01.10.2004
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A novel subtractive fluorescence-activated cell-sorting (FACS) strategy using a model system is described here to identify disease-specific (DS) epitopes from a bacterially displayed random peptide library. In this process, preimmune serum was used as “Driver ” to block any common binding sites on the bacterial surface and the labeled anti-preS IgG polyclonal antibodies from immunized serum were used as “Tester” to enrich preS-specific mimotopes. Bacterial clones were identified out of this pool through an “antigen-independent” procedure only using both different sera samples. After four rounds of sub-FACS screening, 41 out of 50 bacterial clones were identified as reacting with the immunized serum but not reacting with the pre-immune one. Two motif sequences HQLD and DPAF were obtained from 13 clones. Immunization of mice with two representative bacterial clones elicited a strong specific response against native preS antigen in comparison with the control. This technique may provide a useful technology platform for high-throughput screening of disease-related epitope which is of importance to develop vaccine against some infectious diseases whose pathogen or immunodominant antigen is still unknown.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0022-1759
1872-7905
DOI:10.1016/j.jim.2004.06.006